Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Roberto Chacra, Antônio; H. Tan, G.; Marie Apanovitch, Anne; Ravichandran, S.; F. List, James; Chen, R.; the CV181-040 Investigators, for

doi:10.1111/j.1742-1241.2009.02143.x

Public

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Published in International Journal of Clinical Practice • Jul 15, 2009

Authors:

Antônio Roberto Chacra

G. H. Tan

Anne Marie Apanovitch

Abstract

AIMS: Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy. METHODS AND PATIENTS: A total of 768 patients (18-77 years; HbA(...

Subject

Medicine

Type 2 diabetes

Saxagliptin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!